| |
|
Form Serial Number: |
DA20240731E00036
|
| 1.
Date of relevant event: |
31/07/2024
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02190 |
| 4.
Name of listed corporation: |
歸創通橋醫療科技股份有限公司 - B - H股 |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
322,400,744 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
XIE |
| (Other names) |
YANG |
|
|
|
| 10.
Name of director (Chinese): |
谢阳 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1711 | Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
|
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 12,291,418 | 3.79 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 12,291,418 | 3.81 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 珠海通桥投资中心（有限合伙） | 珠海市横琴新区环岛东路1889号21栋411室15卡位 | 谢阳 | 40.00 | Y | |
| 杭州涪江投资合伙企业（有限合伙） | 浙江省杭州市余杭区仓前街道数云路270号B座6层603室 | 谢阳 | 49.30 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
表格24及27：公司7月31日注销回购的共2,219,000H股普通股，注销之后，公司已发行H股股数为322,400,744（注：谢阳在珠海通桥投资中心（有限合伙）持有40.00%的经济利益及在杭州涪江投资合伙企业（有限合伙）持有49.30%的经济利益，珠海通桥及杭州涪江均为僱员激励平台，因此，谢阳被视为通过珠海通桥于8,141,222股H股中及通过杭州涪江于3,750,196股H股中拥有权益，但谢阳并非此等平台涉及的一致行动协议的一致行动人。）
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
31/07/2024
(dd/mm/yyyy)
|
| |